COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE

NIH RePORTER · NIH · N01 · $20,980,989 · view on reporter.nih.gov ↗

Abstract

To provide expertise and state-of-the-art approaches to manufacture, formulate, optimize, and evaluate the safety and toxicity of innovative, cutting-edge influenza vaccine platforms and approaches.

Key facts

NIH application ID: 10192488
Project number: 75N93019C00053-P00002-9999-1
Recipient: DUKE UNIVERSITY
Principal Investigator: MATTHEW JOHNSON
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $20,980,989
Award type: —
Project period: 2019-08-26 → 2024-02-25